These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 196859)
1. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man. Hendy GN; Tomlinson S; O'Riordan JL Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859 [TBL] [Abstract][Full Text] [Related]
2. Reversible resistance to the renal action of parathyroid hormone in man. Tomlinson S; Hendy GN; Pemberton DM; O'Riordan JL Clin Sci Mol Med; 1976 Jul; 51(1):59-69. PubMed ID: 181194 [TBL] [Abstract][Full Text] [Related]
3. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans. Søvik O; Heiervang E; Aksnes L; Selvig S Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266 [TBL] [Abstract][Full Text] [Related]
4. Role of cyclic AMP in glucagon-induced stimulation of hepatic glucose output in man. Grill V; Cerasi E; Wahren J Scand J Clin Lab Invest; 1979 Dec; 39(8):689-96. PubMed ID: 231294 [TBL] [Abstract][Full Text] [Related]
5. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses. Law WM; Heath H J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905 [TBL] [Abstract][Full Text] [Related]
6. The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Siddle K; Davies CJ; Shetty KJ; Elkeles RS Clin Sci Mol Med; 1976 Jun; 50(6):487-91. PubMed ID: 179751 [TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment. Waller DG; Albano JD; Millar JG; Polak A Clin Sci (Lond); 1984 May; 66(5):557-9. PubMed ID: 6323091 [TBL] [Abstract][Full Text] [Related]
8. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862 [TBL] [Abstract][Full Text] [Related]
9. Influence of somatostatin on plasma cyclic AMP and metabolic substrate responses to i.v. adrenaline and glucagon in humans. Nistrup Madsen S; Christensen SE; Hansen AP; Thode J Clin Endocrinol (Oxf); 1981 Nov; 15(5):431-7. PubMed ID: 6120054 [TBL] [Abstract][Full Text] [Related]
10. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612 [TBL] [Abstract][Full Text] [Related]
11. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine. Craven PA; Derubertis FR Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313 [TBL] [Abstract][Full Text] [Related]
13. The rapid changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase activities after intravenous glucagon in humans. Greene HL; Taunton OD; Stifel FB; Herman RH J Clin Invest; 1974 Jan; 53(1):44-51. PubMed ID: 4357616 [TBL] [Abstract][Full Text] [Related]
14. Glucagon effects on plasma cyclic AMP and other reactants in normals and low insulin responders. Israelsson B; Fex G; Malmquist J; Nordén G Acta Med Scand; 1978; 204(1-2):85-7. PubMed ID: 210635 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis. Francavilla A; Jones AF; Starzl TE Gastroenterology; 1978 Dec; 75(6):1026-32. PubMed ID: 213345 [TBL] [Abstract][Full Text] [Related]
16. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion. Forte LR; Nickols GA; Anast CS J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088 [TBL] [Abstract][Full Text] [Related]
17. Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine. Broadus AE; Kaminsky NI; Northcutt RC; Hardman JG; Sutherland EW; Liddle GW J Clin Invest; 1970 Dec; 49(12):2237-45. PubMed ID: 5480850 [TBL] [Abstract][Full Text] [Related]
18. Effect of glucagon infusion on blood glucose, plasma immunoreactive insulin, growth hormone and adenosine 3'5'-monophosphate in obese children. Molnár D; Kardos M; Soltész G Acta Paediatr Acad Sci Hung; 1981; 22(4):325-9. PubMed ID: 6282041 [TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide: effects on pancreatic-adrenal hormone secretion and glucose-lipid metabolism in normal conscious dogs. Kawai K; Yokota C; Ohashi S; Isobe K; Suzuki S; Nakai T; Yamashita K Metabolism; 1994 Jun; 43(6):739-44. PubMed ID: 8201964 [TBL] [Abstract][Full Text] [Related]
20. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man. Messerli FH; Kuchel O; Tolis G; Hamet P; Fraysse J; Genest J Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]